Results 251 to 260 of about 1,620,741 (300)

Periorbital hyperpigmentation as the initial manifestation of smoldering multiple myeloma in a patient with coexisting gastrointestinal stromal tumor: a case report and narrative literature review. [PDF]

Front Oncol
Yang Y, Xu W, Li X, Guo Z.
europepmc   +1 more source

Correction to "Rare Double Primary Malignancies: A Pancreatic Gastrointestinal Stromal Tumor Mimicking as a Metastatic Lesion of Myoepithelial Carcinoma of Parotid Gland". [PDF]

Case Rep Med
europepmc   +1 more source

Gastrointestinal stromal tumor – A review of clinical studies

Journal of Oncology Pharmacy Practice, 2019
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. With the advent of Imatinib, the treatment of gastrointestinal stromal tumor has been revolutionized as both the progression-free and overall ...
Ardavan Khoshnood
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Gastrointestinal stromal tumors

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2006
We reviewed radiologic features of gastrointestinal stromal tumors (GISTs) and correlated them with clinical and pathologic findings.We investigated a series of 39 c-Kit-positive GISTs. Clinical and radiologic findings and management of these patients were recorded.Twenty women and 19 men (mean age 64 years) had histologically proved GIST.
R, Kottke, S, Ioanoviciu, M, Horger
openaire   +4 more sources

Gastrointestinal stromal tumor

Surgical Oncology, 2008
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. These form a distinct category of tumors characterized by oncogenic mutations of the KIT receptor tyrosine kinase in a majority of patients. KIT is used not only for diagnosis but also for targeted therapy of GISTs.
Puneet, Gupta, Mallika, Tewari, Hari S, Shukla   +2 more
openaire   +2 more sources

Gastrointestinal Stromal Tumors

Hematology/Oncology Clinics of North America, 2005
Gastrointestinal stromal tumors (GISTs) are identified pathologically by the expression of KIT. The management of GISTs has been altered significantly by the development of imatinib mesylate, a tyrosine kinase inhibitor with activity against KIT and platelet-derived growth factor receptors.
Margaret, von Mehren, James C, Watson
openaire   +2 more sources

Gastrointestinal stromal tumors

Virchows Archiv, 2010
Gastrointestinal stromal tumors (GISTs) have emerged from being poorly defined, treatment-resistant tumors to a well-recognized, well-understood, and treatable tumor entity within only one decade. The understanding of GIST biology has made this tumor a paradigm for molecularly targeted therapy in solid tumors and provides informative insights into the ...
Bernadette, Liegl-Atzwanger, Jonathan A, Fletcher, Christopher D M, Fletcher   +2 more
openaire   +2 more sources

Gastrointestinal Stromal Tumors

American Journal of Therapeutics, 2016
The understanding of aberrant molecular pathways that result in gastrointestinal stromal tumors (GISTs) and the rapid development of molecular therapies that target these pathways represent one of the great milestones in translational oncology.
Aakanksha Prasad, Asija, Alex V, Mejia, Anthony, Prestipino, Madhavan V, Pillai   +3 more
openaire   +2 more sources

Gastrointestinal stromal tumors

Current Treatment Options in Oncology, 2000
The nonepithelial, nonlymphoid tumors of the gastrointestinal tract are heterogeneous in terms of clinical presentation, behavior, pathology, and genetic features. Concepts regarding these tumors have changed rapidly over the past decade as nomenclature has evolved. Many of these tumors have no muscle differentiation, and designations such as leiomyoma
openaire   +2 more sources